DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20200580

Effect of glutamine supplement on chemo-radiation induced mucositis in head and neck cancer patients: a prospective study

Bishnu Prasad Das, Jitendra Patra

Abstract


Background: Radiotherapy is one of the primary modalities of cancer treatment but may associated with short and long-term toxicities. Oral mucositis is frequently encountered in head and neck cancer resulting in unplanned treatment breaks. Few studies emphasized that use of oral glutamine may significantly reduce oral mucositis and other acute toxicities. This study aims to assess the effects of glutamine on oral mucositis in head and neck cancer patients receiving chemo-radiation.

Methods: It is a prospective study carried out in sixty-four head and neck cancer patients attending radiotherapy department for chemo-radiation from January 2018 to May 2019. Patients were randomly assigned into two arms containing 32 subjects in each. All the patients in arm-A were taking oral glutamine supplement of 15 mg once daily, two hours prior to radiation and arm-B serve as the control group. Dose of radiation fixed at 66 Gy in 33 fractions over a period of 7 weeks along with an infusion of weekly cisplatin (40 mg/m2). Patients were evaluated regarding onset, severity and the recovery period of mucositis.

Results: Oral mucositis appeared at around 5th week in arm-A and 3rd week in arm-B (p<0.0001). Number of patients with mucositis is significantly less in arm-A (75%, 24 out of 32) as compared to arm-B (96.8%) (p=0.0310). The time required for healing of mucositis is significantly less than 1 week in arm-A compared to ~2 weeks in the arm-B (p<0.0001).

Conclusions: Oral glutamine when given prior to radiation results in delayed onset of oral mucositis with decreased severity and an early healing period.

 


Keywords


Oral glutamine, Head and neck cancer, Mucositis, Radiation toxicities

Full Text:

PDF

References


Dose AM. The symptom experience of mucositis, stomatitis, and xerostomia. Semin Oncol Nurs. 1995;11:248-55.

Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy. 2005;25(4):540-4.

Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106(2):329-36.

Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with headand- neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-20.

Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253-62.

Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2007(4):Cd000978.

Stokman MA Vries EG. Preventive intervention possibilities in radiotherapy and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res. 2006;85(8):690.

Newsholme P, Lima MMR, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003;36:153-63.

Souba WW. Glutamine and cancer. Ann Surg. 1993;218(6):715-28.

Furst P, Albers S, Stehle P. Evidence for a nutritional need for glutamine in catabolic patients. Kidney Int. 1989;27:287-92.

Ardawi MS, Newsholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem J. 1983;212:835‑42.

Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plumley DA, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990;66:62‑8.

Silverman S Jr. Diagnosis and management of oral mucositis. J Support Oncol. 2007;5(suppl 1):13‑21.

Mead GM. Management of oral mucositis associated with cancer chemotherapy. Lancet. 2002;359:815‑6.

Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995-2025.

Symonds RP, McIlroy P, Khorrami J, Paul J, Pyper E, Alcock SR, et al. The reduction of radiation mucositis by selective decontamination antibiotic pastilles: A placebo-controlled double-blind trial. Br J Cancer. 1996;74:312-7.

Rovirosa A, Ferre J, Biete A. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:747-54.

Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: A randomized trial. Blood. 2007;109:2250-5.

Tsujimoto T, Yamamoto Y, Wasa M, Takenaka Y, Nakahara S, Takagi T, et al. L-Glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep. 2015;33(1):33-9.

Leung HW, Chan AL. Glutamine in alleviation of radiation-induced severe oral mucositis: a meta-analysis. Nutr Cancer. 2016;68(5):734-42.

Pattanayak L, Panda N, Dash MK, Mohanty S, Samantaray S. Management of Chemoradiation- Induced Mucositis in Head and Neck Cancers with Oral Glutamine. J Global Oncol Am Society Clin Oncol. 2016;2;4200-6.

Huang CJ, Huang MY, Fang PT, Chen F, Wang YT, Chen CH, et al., Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients. Am J Clin Nutr. 2019;109:606-14.

Chattopadhyay S, Saha A, Azam M, Mukherjee A, Sur PK. Role of oral glutamine in alleviation and prevention of radiationinduced oral mucositis: A prospective randomized study. South Asian J Cancer. 2014;3:8-12.